One of most common New Year resolutions is to lose weight. Weight loss could be more achievable prospect in 2024 because of recently-approved injectable drugs that have proven to be particularly effective in helping people shed kilos (or pounds). They belong to class of medications called GLP-1. most well known of these are Wegovy and Ozempic. drugs.com website reported that in extensive studies of patients using Wegovy, 83 per cent of participants lost 5 per cent or more of their weight compared to 31 per cent of those taking placebo. cardiologist at Mayo Clinic said obesity drugs "are here to stay" and that "more and more of these drugs are coming to market".
The significance of new remedies has been highlighted by industry experts. The prestigious journal "Science" declared family of weight-loss drugs to be medicine's "breakthrough of year" for 2023. This year could prove to be even better for overweight people, and for those who find exercising difficult. new drug called Zepbound has been approved. In clinical trials, people taking this lost average of 20-25 per cent of their weight. Obesity specialist, doctor Juliana Simonetti, said new drugs were "amazing, since they address underlying physiological cause of weight regain". She added: "I've been working in this field over last decade, and results are very impressive."
